Death By Supermarket (37 page)

66
“Carbohydrate Addiction,” accessed December 1, 2005,
http://www.americanheart.org/presenter.jhtml?identifier=4467
; J. Barua and A. Bal, “Emerging Facts About Aspartame,”
Journal Of The Diabetic Association Of India
35, no.4 (1995): 92-107.

67
Olney et al., “Increasing Brain Tumor Rates,” 1115-1123; Morando Soffritti et al., “First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats,”
Environmental Health Perspectives
114, no. 3 (March 2006): 379-385; J.D. Smith et al., “Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins”
The Annals of Pharmacotherapy
35, no. 6 (2001): 702-706; Rapid Responses to: EDITORIALS: Joseph M Mercola, “Aspartame Can Damage Your Health,” John P Briffa, “It’s not just misleading websites that the public should be protected from,” Dr. Janet S Hull, “Aspartame Dangers ARE Real,” John P Briffa,” What Aspartame has in common with any artificial sweetener (“natural” or not) in effects on health,”
BMJ
329 (2004): 755-756; L Kovatsi and M Tsouggas, “The effect of oral aspartame administration on the balance of magnesium in the rat,”
Magnesium Research Journal
3 (September 14, 2001): 189-94; L.C. Newman and R.B. Lipton, “Migraine MLT-down: an unusual presentation of migraine in patients with Aspartame-triggered headaches,”
Headache
41, no. 9 (2001): 899-901; B. Christian et al., “Chronic Aspartame affects maze performance, brain cholinergic receptors and Na+, K+-ATPase in rats,”
Pharmacology, Biochemistry, and Behavior
78, no. 1 (2004): 121-127; Daniel DeNoon, “Rat Study Links Aspartame to Cancer,” accessed November 7, 2005,
http://www.medscape.com/viewarticle/509619
.

68
Michael Friedman, MD, Deputy Commissioner for operations Food and Drug Administration, Department of Health and Human Services (statement made before the subcommittee on human resources and intergovernmental relations committee on government reform and oversight, U.S. House of Representatives, Washington D.C., May 10, 1996). accessed October 24, 2005,
http://www.fda.gov/ola/1996/foodbor.html
.

69
“Federal Food, Drug, and Cosmetic Act,” accessed October 24, 2005,
http://www.fda.gov/opacom/laws/fdcact/fdcact1.htm
,
http://www.fda.gov/opacom/laws/fdcact/fdcact1.htm
; “FDA Backgrounder,” October 1991, accessed October 24, 2005,
http://www.geocities.com/HotSprings/2455/bak-msg.html
.

70
Donald L. Bartlet and James B. Steele, “Deadly Medicine,”
Vanity Fair
, January. 2011, 57-63, 113; M.M. Wolf, D.R. Lichtenstein, and G. Singh, “Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs,”
The New England Journal of Medicine
340 (1999): 1888-1899.

71
“FDA implicated in conflict of interest for manufacturers of COX-2 inhibitor drugs,”
Validation Times
, accessed July 2, 2005,
http://www.fdainfo.com/vtonlinepages/valtimesweb041105.htm
.

72
Gardiner Harris and Alex Berenson, “10 Voters on Panel Backing Pain Pills Had Industry Ties,”
New York Times
, February 25, 2005, A-1.

73
Alex Berenson, “Evidence in Vioxx Suits Shows Intervention by Merck Officials,”
New York Times
, April 24, 2005, National.

74
“Merck announces settlement to end Vioxx lawsuits,” accessed October 7, 2010,
http://www.lehighvalleylive.com/today/index.ssf/2010/02/merck_
announces_settlement_to.html
.

75
Dr. Joseph Mercola, “Finally, the FDA Decides to Curb Avandia - But Did the Agency Go Far Enough?” October 11, 2010, accessed October 12, 2010,
http://www.foodconsumer.org/newsite/Non-food/Drug/avandia_0510101216.html
.

76
Paul D. Thacker, “Glaxo’s Avandia Cover-Up,” September 29, 2010, accessed October 12, 2010,
http://motherjones.com/politics/2010/09/glaxosmithkline-avandia
.

77
Ibid.

78
“Avandia Lawsuit Settlement of $60M Will Resolve 700 Cases: Report,”
Aboutlawsuits.com
, last modified May 11, 2010, accessed October 12, 2010,
http://www.aboutlawsuits.com/avandia-lawsuit-settlement-reached-in-cases-10153/
.

79
Interview with Dr. David Graham, “Prescription Drug Alert: Millions at risk from serious and possibly deadly side effects,”
Crusader
(June/July 2005): 1-8.

80
Deborah Franklin, “Poisonings from a Popular Pain Reliever Are Rising,”
New York Times
, November 29, 2005,
http://wwwnytimes.com/2005/11/29/health/29cons.html?incamp=article_popula&pagewanted=print
. John G. O’Grady, “Broadening the view of acetaminophen hepatotoxicity,”
Hepatology
42, no. 6 (2005): 1252-1254.

81
Center for Disease Control and Prevention, “How Many Children Have Autism?” accessed October 7, 2010,
http://www.cdc.gov/ncbddd/features/counting-autism.html
.

82
Robert F. Kennedy Jr., “Deadly Immunity,” posted June 20, 2010, accessed June 27, 2005,
http://www.rollingstone.com/politics/story/_/id/7395411
;
http://www.robertfkennedyjr.com/articles.html
;
http://www.youtube.com/watch?v=LP39qJLgNw
;
http://www.robertfkennedyjr.com/docs/ThimerosalScandalFINAL.PDF
, accessed October 7, 2010.

83
U.S Food and Drug Administration, “Thimerosal in vaccines,” accessed October 7, 2010,
http://www.fda.gov/biologicsbloodvaccines/safetyavailability/
vaccinesafety/ucm096228.htm
.

84
“The FDA Versus The American Consumer,”
Life Extension Magazine
, October 2002, accessed October 7, 2010,
http://www.lef.org/magazine/mag2002/oct2002_awsi_01.html
.

85
Peter R. Breggin, MD, “Violence and Suicide Caused by Antidepressants Report to the FDA,” August 23, 2004, accessed October 7, 2010,
http://www.breggin.com/index.php?option=com_content&task=view&id=197
.

86
Bob Unruh, “Are meds to blame for Cho’s rampage? Experts say psychiatric drugs linked to long list of school shooting sprees,” WorldNetDaily, April 23, 2007, accessed October 7, 2010,
http://www.wnd.com/?pageId=41218
.

87
Gary G. Kohls, MD, “The Drugs May be the Problem: Inconvenient Truths about Psychotropic Drugs and the Pharmaceutical Industry,” accessed October 7, 2010,
http://www.mindbodymedicineduluth.com/mssa08/20_points.pdf
.

88
Begley, “The Depressing News about Antidepressants.”

89
Samuel Epstein, telephone interview with author, December 21, 2004.

90
Quote from
San Francisco Chronicle
(January 2, 1970),
http://www.advancedhealthplan.com/fdafraud.html
, accessed November 8, 2005.

91
Michael Culbert,
Medical Armageddon
(San Diego, California: C and C Communications, 1997), 333-334.

92
Gardiner Harris, “Top Democrat Finds F.D.A.’s Efforts Have Plunged,”
New York Times
, June 27, 2006, accessed June 29, 2006,
http://www.nytimes.com/2006/06/27/health/policy/27fda.html?ex=1152072000&en=151885b8ace9fb7e&ei=5070&emc=eta1
.

93
Donald G. McNeil, Jr. “Review Finds Scientists with Ties to Companies,”
New York Times
, July 15, 2005, A-15. Meredith Wadman, “One in three scientists confesses to having sinned,”
Nature
435 (June 9, 2005): 718-719.

94 U.S. Food and Drug Administration, “Consumer information about food ingredients and food packages,” accessed November 8, 2005,
http://www.cfsan.fda.gov/~dms/qa-adf9.html
. “Aspartame is safe; the world agrees!” accessed October 7, 2010,
http://www.fitnessandfreebies.com/fitness/aspartame.html
.

95
Earl Mindell and Virginia Hopkins,
Prescription Alternatives 3rd Edition
(McGraw-Hill Companies: September 1, 1999), 6.

96
L. Tollefson, “Monitoring adverse reactions to food additives in the U.S. Food and Drug Administration,”
Regulatory Toxicology and Pharmacology
8, no. 4 (December 1988): 438-46.

97
Russell L. Blaylock, e-mail message to author, March 28, 2005, 12:45 p.m.

98
Christine Northrup, e-mail message to author, July 21, 2004, 3:13 p.m.

99
Bradley Willcox, e-mail message to author, August 23, 2004, 8:45 p.m.

100
“Weil: Your Trusted Health Advisor,” accessed June 13, 2004,
http://www.drweil.com
.

101
Kaayla T. Daniel, e-mail message to author, August 16, 2004, 2:52 p.m.

102
Interested readers can take a look at pro and con research in the “Report on Phytoestrogens and Health” by the British government’s Committee on Toxicity, accessed November 10, 2005,
http://www.food.gov.uk/multimedia/pdfs/phytoreport0503
.

103
Blaylock,
Excitotoxins
, 220;
http://www.westonaprice.org
, accessed March 14, 2005; Kaayla T. Daniel,
The Whole Soy Story: The Dark Side of America’s Favorite Health Food
(Washington DC: New Trends, 2005); Carol Simontacchi, e-mail message to author, Wednesday, June 16, 2004, 8:44 a.m.; Robin Marzi, RD, MA, e-mail message to author, June 17, 2004, 10:32 a.m.; Maoshing Ni, PhD, LAc, DOM, e-mail message to author, August 20, 2004, 2:30 p.m.

104
“FDA scientists questions soy safety—but where is GM testing?” accessed November 10, 2005,
http://www.netlink.de/gen/Zeitung/2000/000609.html
.

105
FDA Talk Paper, “FDA Approves New Health Claim for Soy Protein and Coronary Heart Disease.” accessed June 20, 2004,
http://www.fda.gov/bbs/topics/ANSWERS/ANS00980.html
.

106
Daniel,
The Whole Soy Story
, 295-310, 331-356.

107
Daniel,
The Whole Soy Story
, 363; M. Penotti et al., “Effect of soy-derived isoflavones on hot flashes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries,”
Fertility and Sterility
79, no. 5 (2003):
1112-1117; E. Nikander et al., “A randomized placebocontrolled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients,”
Obstetrics and Gynecolocy
101, no.6 (2003): 1213-1120; J.L. Balk et al., “A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium,”
Journal for the Society of Gynecologic Investigation
9, no. 4 (2002): 238-242; D. Kotsopoulous et al., “The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women,”
Climacteric
3, no. 3 (2000): 161-167; L.J. Lu, J.A. Tice, and F.L. Bellino, “Phytoestrogens and healthy aging: gaps in knowledge,”
Menopause
8, no. 3 (2001): 157-170; Editorial notes from Kaayla T. Daniel on manuscript (September 2005).

108
Kaayla T. Daniel, e-mail message to author, August 16, 2004, 2:52 p.m.

109
Marian Burros, “Eating Well: Doubts Cloud Rosy News on Soy,”
New York Times
, January 26, 2000, Dining In, Dining Out/Style Desk.

110
Mike Fitzpatrick, “Soy Formulas and the Effects of Isoflavones on the Thyroid,”
New Zealand Medical Journal
113 (February 11, 2000): 24.

111
John C. Lowe, “Four 2003 Studies of Thyroid Hormone Replacement Therapies: Logical Analysis and Ethical Implications.” accessed November 10, 2005,
http://www.drlowe.com/frf/t4replacement/Critique.Replacement.Studies.pdf
.

112
Bradley Willcox, e-mail message to author, August 23, 2004, 8:45 p.m.

113
Kaayla T. Daniel, e-mail message to author, December 18, 2005, 6:22 p.m.

114
David Zava, e-mail message to author, June 22, 2004, 6:35 a.m.

115
http://www.accesseonline.com/printstoryb.php?type=travel&id=3
;
http://www.clearspring.co.uk/pages/site/products/macro/info1.html
;
http://www.hi-net.zaq.ne.jp/yossy/global_education/example/note.html
;
http://en.wikipedia.org/wiki/Japanese_cuisine
,
http://www.members.tripod.com/~Doc_In_The_Kitchen/japan
, accessed November 11, 2005.

116
Daniel,
The Whole Soy Story
, 53.

117
Jeffrey M. Smith,
Seeds of Deception: Exposing Industry and Government Lies About the Safety of the Genetically Engineered Foods You’re Eating
(Fairfield, IA: Yes! Books, 2002), 1.

118
Anon. “Health risks of genetically modified foods.”
Lancet
353, no. 9167 (1999): 181.

119
Ibid.

120
Ronnie Cummins, “Hazards of Genetically Engineered Foods and Crops: Why We Need A Global Moratorium,” Organic Consumers Association,
http://www.organicconsumers.org/ge/gefacts.pdf
.

121
Steven Sprinkel, “When The Corn Hits The Fan,” September 18, 1999, accessed October 9, 2010,
http://www.mindfully.org/GE/Sprinkel-Corn-Hits-Fan.htm
.

122
PureZing, “GMO / Genetically Modified Foods,” accessed October 9, 2010,
http://www.purezing.com/living/toxins/living_toxins_gmofoods.html
.

123
J. J. Rackis, M. R. Gumbmann, and I. E. Liener, “The USDA trypsin inhibitor study. I. Background, objectives, and procedural details,”
Plant Foods for Human Nutrition, (Formerly Qualitas Plantarum)
(Historical Archive) 35, no. 3 (September 1985): 213-242; “Evaluation of the Health Aspects of Soy Protein Isolates as Food Ingredients,” Prepared for FDA by Life Sciences Research Office,
Federation of American Societies for Experimental Biology
(1979), Contract No. FDA 223-75-2004; Daniel,
The Whole Soy Story
, 93, 260-266.

124
Daniel,
The Whole Soy Story
, 95.

125
Enig and Fallon,
Eat Fat, Lose Fat
, 97, 99.

126
Joanne K. Tobacman, “Review of Harmful Gastrointestinal Effects of Carrageenan in Animal Experiments.
Environmental Health Perspective
109, no.10 (October 2001): 983-94.